STE
Price
$212.61
Change
-$8.80 (-3.97%)
Updated
Apr 4 closing price
Capitalization
22.22B
44 days until earnings call
SYK
Price
$345.80
Change
-$22.35 (-6.07%)
Updated
Apr 4 closing price
Capitalization
134.94B
24 days until earnings call
Ad is loading...

STE vs SYK

Header iconSTE vs SYK Comparison
Open Charts STE vs SYKBanner chart's image
STERIS
Price$212.61
Change-$8.80 (-3.97%)
Volume$1.2M
Capitalization22.22B
Stryker
Price$345.80
Change-$22.35 (-6.07%)
Volume$3.96M
Capitalization134.94B
STE vs SYK Comparison Chart
Loading...
STE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
STE vs. SYK commentary
Apr 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is STE is a StrongBuy and SYK is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 07, 2025
Stock price -- (STE: $212.61 vs. SYK: $345.80)
Brand notoriety: STE and SYK are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: STE: 209% vs. SYK: 256%
Market capitalization -- STE: $22.22B vs. SYK: $134.94B
STE [@Medical Specialties] is valued at $22.22B. SYK’s [@Medical Specialties] market capitalization is $134.94B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

STE’s FA Score shows that 0 FA rating(s) are green whileSYK’s FA Score has 2 green FA rating(s).

  • STE’s FA Score: 0 green, 5 red.
  • SYK’s FA Score: 2 green, 3 red.
According to our system of comparison, SYK is a better buy in the long-term than STE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

STE’s TA Score shows that 3 TA indicator(s) are bullish while SYK’s TA Score has 3 bullish TA indicator(s).

  • STE’s TA Score: 3 bullish, 7 bearish.
  • SYK’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, SYK is a better buy in the short-term than STE.

Price Growth

STE (@Medical Specialties) experienced а -4.66% price change this week, while SYK (@Medical Specialties) price change was -4.91% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -6.38%. For the same industry, the average monthly price growth was -2.87%, and the average quarterly price growth was -1.88%.

Reported Earning Dates

STE is expected to report earnings on Aug 11, 2025.

SYK is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Medical Specialties (-6.38% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SYK($135B) has a higher market cap than STE($22.2B). SYK has higher P/E ratio than STE: SYK (42.99) vs STE (38.85). STE YTD gains are higher at: 3.697 vs. SYK (-3.736). SYK has higher annual earnings (EBITDA): 4.93B vs. STE (1.39B). SYK has more cash in the bank: 3.05B vs. STE (196M). STE has less debt than SYK: STE (3.51B) vs SYK (13B). SYK has higher revenues than STE: SYK (20.5B) vs STE (5.41B).
STESYKSTE / SYK
Capitalization22.2B135B16%
EBITDA1.39B4.93B28%
Gain YTD3.697-3.736-99%
P/E Ratio38.8542.9990%
Revenue5.41B20.5B26%
Total Cash196M3.05B6%
Total Debt3.51B13B27%
FUNDAMENTALS RATINGS
STE vs SYK: Fundamental Ratings
STE
SYK
OUTLOOK RATING
1..100
7966
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
20
Undervalued
PROFIT vs RISK RATING
1..100
3911
SMR RATING
1..100
7854
PRICE GROWTH RATING
1..100
5457
P/E GROWTH RATING
1..100
4834
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SYK's Valuation (20) in the Medical Specialties industry is somewhat better than the same rating for STE (66). This means that SYK’s stock grew somewhat faster than STE’s over the last 12 months.

SYK's Profit vs Risk Rating (11) in the Medical Specialties industry is in the same range as STE (39). This means that SYK’s stock grew similarly to STE’s over the last 12 months.

SYK's SMR Rating (54) in the Medical Specialties industry is in the same range as STE (78). This means that SYK’s stock grew similarly to STE’s over the last 12 months.

STE's Price Growth Rating (54) in the Medical Specialties industry is in the same range as SYK (57). This means that STE’s stock grew similarly to SYK’s over the last 12 months.

SYK's P/E Growth Rating (34) in the Medical Specialties industry is in the same range as STE (48). This means that SYK’s stock grew similarly to STE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
STESYK
RSI
ODDS (%)
Bearish Trend 3 days ago
48%
Bullish Trend 3 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
52%
Bearish Trend 3 days ago
54%
Momentum
ODDS (%)
Bearish Trend 3 days ago
64%
Bearish Trend 3 days ago
51%
MACD
ODDS (%)
Bearish Trend 3 days ago
43%
Bearish Trend 3 days ago
49%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
54%
Bearish Trend 3 days ago
49%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
50%
Bearish Trend 3 days ago
44%
Advances
ODDS (%)
Bullish Trend 11 days ago
58%
Bullish Trend 5 days ago
58%
Declines
ODDS (%)
Bearish Trend 3 days ago
50%
Bearish Trend 3 days ago
49%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
68%
Bullish Trend 3 days ago
66%
Aroon
ODDS (%)
Bullish Trend 3 days ago
59%
Bearish Trend 3 days ago
41%
View a ticker or compare two or three
Ad is loading...
STE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FNGR1.410.03
+2.17%
FingerMotion
ROCK52.51-1.00
-1.87%
Gibraltar Industries
PTPI0.07N/A
-2.19%
Petros Pharmaceuticals
VEL17.95-0.55
-2.97%
Velocity Financial
CYBR306.46-21.50
-6.56%
CyberArk Software Ltd